We report the results of the investigation of safety and efficacy of venous angioplasty in patients with multiple sclerosis ( MS ) with findings of extracranial venous anomalies , considered hallmarks of chronic cerebrospinal venous insufficiency ( CCSVI ) , in a 2-phase study ( ClinicalTrials.gov NCT01450072 ) .